SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-19-000232
Filing Date
2019-08-27
Accepted
2019-08-27 16:31:52
Documents
7
Period of Report
2019-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 24413
2 FORM OF WARRANT exh4-1.htm EX-4.1 66413
3 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP exh5-1.htm EX-5.1 7422
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AUGUST 23, 2019 exh10-1.htm EX-10.1 151134
5 PLACEMENT AGENCY AGREEMENT, DATED AUGUST 23, 2019 exh10-2.htm EX-10.2 73629
6 FORM OF LEAK-OUT AGREEMENT exh10-3.htm EX-10.3 12421
7 LOGO image4055.jpg GRAPHIC 64418
  Complete submission text file 0001136261-19-000232.txt   425624
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 191057706
SIC: 2834 Pharmaceutical Preparations